Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer
| Status: | Terminated |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/28/2019 |
| Start Date: | September 2008 |
| End Date: | December 2009 |
Phase II Study of Maintenance of Tarceva (Erlotinib) in Patients With Locally Advanced Head and Neck Cancer
Phase II Study of Maintenance Tarceva (Erlotinib) in patients with locally advanced Head and
Neck Cancer after treatment with curative intent
Neck Cancer after treatment with curative intent
Inclusion Criteria:
- Stage III, IV SCCHN
- Completed curative treatment
Exclusion Criteria:
- Prior chemotherapy or radiotherapy
- Recurrent disease
We found this trial at
1
site
Click here to add this to my saved trials
